Sign in
Back
A Phase II Trial of Continuous-Infusion Recombinant Interleukin-2 in Patients with Advanced Renal Cell Carcinoma: A Southwest Oncology Group Study
Journal article   Peer reviewed

A Phase II Trial of Continuous-Infusion Recombinant Interleukin-2 in Patients with Advanced Renal Cell Carcinoma: A Southwest Oncology Group Study

Robert P Whitehead, Michael K Wolf, Dilip L Solanki, George P Hemstreet, Pasquale Benedetto, Stephen P Richman, Robert C Flanigan and E. David Crawford
Journal of immunotherapy (1997), Vol.18(2), pp.104-114
1995-08
DOI: https://doi.org/10.1097/00002371-199508000-00004
PMID: 8574465

Metrics

13 Record Views
10 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.6 Immunology
1.6.358 Dendritic Cells
Web Of Science research areas
Immunology
Medicine, Research & Experimental
Oncology
ESI research areas
Immunology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details